Singular Genomics Systems Inc reports results for the quarter ended in December - Earnings Summary

Singular Genomics Systems

02/03/2023 22:03

* Singular Genomics Systems Inc  OMIC.OQ  reported a
quarterly
adjusted loss of 29 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 43 cents per share.
    * Revenue was $765.00 thousand​; analysts expected $759.80
thousand. 
    * Singular Genomics Systems Inc's reported EPS for the
quarter was
a loss of 29 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Singular Genomics Systems Inc shares had fallen by 2.5%
this
quarter.
    * The company reported a quarterly loss of $21.1 million.
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $2.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 2
at 10:03 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.43          -0.29          Beat
 Sep. 30 2022      -0.41          -0.33          Beat
 Jun. 30 2022      -0.38          -0.34          Beat
 Mar. 31 2022      -0.33          -0.31          Beat